Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 31 - Medicinal preparations containing organic active ingredients
Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912)
03/1999
03/25/1999WO1999014235A1 Persephin and related growth factors
03/25/1999WO1999014231A2 Bifidus stimulating peptides and its uses
03/25/1999WO1999014226A2 Bi- and tri-cyclic nucleoside, nucleotide and oligonucleotide analogues
03/25/1999WO1999014218A1 Carbapenem derivatives and a preparation method thereof
03/25/1999WO1999014217A1 Aryloxymethyl carbapenem antibacterials
03/25/1999WO1999014215A1 4-heteroaryl-tetrahydroquinolines and their use as inhibitors of the cholesterin-ester transfer protein
03/25/1999WO1999014214A1 Antimicrobial quinolones, their compositions and uses
03/25/1999WO1999014213A1 Substituted chroman derivatives
03/25/1999WO1999014212A1 Substituted chroman derivatives
03/25/1999WO1999014211A1 α-PYRONES FOR TREATING α-PYRONE RESPONSIVE STATES
03/25/1999WO1999014209A1 New taxane derivatives
03/25/1999WO1999014207A1 Substituted indan derivatives
03/25/1999WO1999014205A1 New 2-(3h)-oxazolone derivatives
03/25/1999WO1999014199A1 Substituted 1,2,3,4,5,6-hexahydro-2,6-methano-3-benzazocine-10-oles, method for the production and use thereof as medicaments
03/25/1999WO1999014197A1 Substituted isoquinolines as anticonvulsivants
03/25/1999WO1999014196A1 Method for the synthesis of quinoline derivatives
03/25/1999WO1999014195A1 2-aminopyridines as inhibitors of cyclooxygenase-2
03/25/1999WO1999014194A1 2,3,5-trisubstituted pyridines as inhibitors of cyclooxygenase-2
03/25/1999WO1999014185A1 Compounds containing six-membered rings, processes for their preparation, and their use as medicaments
03/25/1999WO1999013920A2 Method for treating proliferative diseases by therapy
03/25/1999WO1999013915A1 Method of delivering genes to antigen presenting cells of the skin
03/25/1999WO1999013914A1 Pharmaceutical compositions containing plasma protein
03/25/1999WO1999013911A1 Nootropic agent
03/25/1999WO1999013902A1 Product for promoting dural or meningeal tissue growth comprising collagen
03/25/1999WO1999013893A1 Peptide nucleic acids having antibacterial activity
03/25/1999WO1999013888A1 Germicidal compositions for the treatment of animal infectious diseases of the hoof, comprising a copper salt, a quaternary ammonium compound and a peroxide
03/25/1999WO1999013887A1 Burn treatment composition
03/25/1999WO1999013886A1 Multiple target hybridizing nucleic acids, their preparation, compositions, formulation, kits and applications
03/25/1999WO1999013885A1 Modulation of immune responses
03/25/1999WO1999013884A1 Compositions and methods useful for the treatment of neurological and mental disorders
03/25/1999WO1999013883A1 Androgen as a male contraceptive and non-contraceptive androgen replacement
03/25/1999WO1999013882A1 Oral contraceptive preparation having a first phase comprising progestin/estrogen and a second phase comprising progestin
03/25/1999WO1999013880A1 C-c chemokine production inhibitor
03/25/1999WO1999013879A1 Pharmaceutical compositions containing a monoamine oxydase inhibitor and their use in therapy
03/25/1999WO1999013878A1 A COMBINATION OF A MONOAMINE OXIDASE INHIBITOR AND A h5-HT1B ANTAGONIST OR PARTIAL AGONIST
03/25/1999WO1999013877A1 A COMBINATION OF A 5-HT REUPTAKE INHIBITOR AND A h5-HT1B ANTAGONIST OR PARTIAL AGONIST
03/25/1999WO1999013876A1 A COMBINATION OF A SELECTIVE 5-HT1A ANTAGONIST AND A SELECTIVE h5-HT1B ANTAGONIST OR PARTIAL AGONIST
03/25/1999WO1999013875A1 Use of nitroxides for the treatment of essential hypertension
03/25/1999WO1999013874A1 Treating/preventing heart failure via inhibition of mast cell degranulation
03/25/1999WO1999013873A1 Agent for treating patients suffering from tumours
03/25/1999WO1999013872A1 Antimicrobials
03/25/1999WO1999013867A1 Methods and compositions for treating pulmonary disorders using optically pure (s)-salmeterol
03/25/1999WO1999013865A1 Sustained-release liposomal anesthetic compositions
03/25/1999WO1999013863A1 Ophthalmic composition including a cationic glycoside and an anionic therapeutic agent
03/25/1999WO1999013862A2 A pharmaceutical composition for treating dysmenorrhea and premature labor
03/25/1999WO1999013821A1 Hair conditioners for treating split ends
03/25/1999WO1999013819A2 Composition and method for reducing stinging in skin
03/25/1999WO1999013816A2 Liposomal camptothecin formulations
03/25/1999WO1999013812A1 Transdermal administration of ment
03/25/1999WO1999013799A1 Synergistic analgesic combination of opioid analgesic and cyclooxygenase-2 inhibitor
03/25/1999WO1999013739A1 Fatty acids as a diet supplement
03/25/1999WO1999013738A1 Organ specific nutrition
03/25/1999WO1999013721A1 Pharmaceutical compositions and methods for the treatment of failing myocardial tissue
03/25/1999WO1999013717A1 A delivery of arginine to cause beneficial effects
03/25/1999WO1999013714A1 Antifungal agents
03/25/1999WO1999007383B1 Composition and method for regulating cell proliferation and cell death
03/25/1999WO1999003822A8 Bicyclic metabotropic glutamate receptor ligands
03/25/1999WO1999001463A3 Modified glycosides, compositions comprised thereof and methods of use thereof
03/25/1999WO1999001427A3 Novel nitric oxide-releasing amidine- and enamine-derived diazeniumdiolates, compositions and uses thereof and method of making same
03/25/1999WO1999001109A3 Therapeutical system for transdermal delivery of levonorgestrel
03/25/1999WO1999000654A3 Radiolabeled farnesyl-protein transferase inhibitors
03/25/1999WO1999000436A3 Polymerisates of unsaturated saccharide acids and their derivatives, copolymerisates thereof with ethylenically unsaturated compounds and method for preparing the same
03/25/1999WO1998051665A3 Novel macrocyclic compounds as metalloprotease inhibitors
03/25/1999WO1998051330A9 Method and compositions for treating hyperlipidemia and other conditions
03/25/1999WO1998050530A9 Enzymatic nucleic acids: synthesis, selection and use
03/25/1999WO1998050032A9 BETA-LACTAM INHIBITORS OF CoA-IT
03/25/1999WO1998048027A3 Materials and methods for treatment of retinal diseases
03/25/1999WO1998048009A3 Materials and methods for ribozyme treatment of retinal diseases
03/25/1999WO1998047518A9 Use of cholesterol-lowering agents to influence signal transduction processes in the cell membrane and in the prophylaxis or treatment of prion-associated diseases or alzheimer's disease
03/25/1999WO1998047505A9 Neuropeptide y receptor antagonist
03/25/1999DE19742096A1 Use of sodium/hydrogen ion exchanger inhibitor to treat and prevent central nervous system disorders, e.g. epilepsy and psychotic disorders
03/25/1999DE19742014A1 Use of new and known tetracyclene compounds as phospholipase inhibitors
03/25/1999DE19741738A1 Linker nucleoside(s) containing alkenyloxy or phthalimido-alkyl groups
03/25/1999DE19741542A1 Use of mast cell stabilizers to prevent rejection of fetuses and related abortion disorders
03/25/1999DE19741400A1 New benzyl-biphenyl derivatives
03/25/1999DE19741399A1 New tetrahydroquinoline derivatives useful in treatment of elevated lipid levels and arteriosclerosis
03/25/1999DE19741051A1 New tetrahydroquinoline derivatives useful in treatment of raised lipid levels and arteriosclerosis
03/25/1999CA2469084A1 Androgen as a male contraceptive and non-contraceptive androgen replacement
03/25/1999CA2304982A1 Sense mrna therapy
03/25/1999CA2304312A1 Multiple target hybridizing nucleic acids, their preparation, compositions, formulation, kits and applications
03/25/1999CA2304267A1 Aryloxymethyl carbapenem antibacterials
03/25/1999CA2304265A1 Methods and compositions for treating pulmonary disorders using optically pure (s)-salmeterol
03/25/1999CA2304119A1 Modulation of immune responses
03/25/1999CA2304037A1 Substituted chroman derivatives
03/25/1999CA2303926A1 Substituted chroman derivatives
03/25/1999CA2303839A1 Substituted indan derivatives
03/25/1999CA2303777A1 Substituted isoquinolines as anticonvulsivants
03/25/1999CA2303366A1 Liposomal camptothecin formulations
03/25/1999CA2303323A1 Compounds containing six-membered rings, processes for their preparation, and their use as medicaments
03/25/1999CA2303299A1 Bi- and tri-cyclic nucleoside, nucleotide and oligonucleotide analogues
03/25/1999CA2303104A1 Hair conditioners for treating split ends
03/25/1999CA2303026A1 Method for the synthesis of quinoline derivatives
03/25/1999CA2302782A1 Asthma associated factors as targets for treating atopic allergies including asthma and related disorders
03/25/1999CA2302383A1 A combination of a selective 5-ht1a antagonist and a selective h5-ht1b antagonist or partial agonist
03/25/1999CA2302382A1 A combination of a 5-ht reuptake inhibitor and a h5-ht1b antagonist or partial agonist
03/25/1999CA2302316A1 Method of delivering genes to antigen presenting cells of the skin
03/25/1999CA2302251A1 Antimicrobial agent
03/25/1999CA2302204A1 A combination of a monoamine oxidase inhibitor and a h5-ht1b antagonist or partial agonist
03/25/1999CA2301887A1 Method for treating proliferative diseases by therapy
03/25/1999CA2301782A1 Nootropic agent
1 ... 6522 6523 6524 6525 6526 6527 6528 6529 6530 6531 6532 6533 6534 6535 6536 6537 6538 6539 6540 6541 6542 ... 7860